Redox therapy in neonatal sepsis: reasons, targets, strategy, and agents.

  title={Redox therapy in neonatal sepsis: reasons, targets, strategy, and agents.},
  author={Milica Baj{\vc}eti{\'c} and Snezana D. Spasic and Ivan Spasojevi{\'c}},
  volume={42 3},
Neonatal sepsis is one of the most fulminating conditions in neonatal intensive care units. Antipathogen and supportive care are administered routinely, but do not deliver satisfactory results. In addition, the efforts to treat neonatal sepsis with anti-inflammatory agents have generally shown to be futile. The accumulating data imply that intracellular redox changes intertwined into neonatal sepsis redox cycle represent the main cause of dysfunction of mitochondria and cells in neonatal sepsis… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS


Publications referenced by this paper.
Showing 1-10 of 84 references

Neonatal invasive fungal infection in England 2004-2010.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases • 2014
View 2 Excerpts

Antibiotic resistanceVthe need for global solutions

R Laxminarayan, A Duse, +7 authors H Goossens
Lancet Infect Dis 13(12):1057Y1098, • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…